首頁 > 市場調查報告書 > 製藥

臨床實驗

市場調查報告書

商品編碼

1735684

全球豬流感疫苗市場規模（依產品類型、應用、區域範圍、預測）

Global Swine Influenza Vaccines Market Size By Product Type (Live Vaccine, Killed Vaccine), By Application (Commodity Pig, Breeding Pig), By Geographic Scope And Forecast

出版日期: 2025年05月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

豬流感疫苗市場規模及預測

過去幾年，豬流感疫苗市場規模一直快速成長，成長率顯著，預計在預測期內（即 2026-2032 年）將大幅成長。

豬流感，又稱為豬流感，是一種由感染豬的流感病毒引起的呼吸道疾病。該疾病也可傳播給人類，導致人類豬流感疫情爆發。
全球豬流感市場包括疫苗和治療劑的開發、製造和分銷。
豬流感疫苗和治療方法的應用主要集中在預防和治療豬和人類的疾病。對豬來說，接種疫苗是為了防止疾病的傳播，但這會給農民帶來巨大的經濟損失。對於人類來說，豬流感疫苗和治療方法用於預防和治療這種疾病，這種疾病會導致呼吸道疾病，在嚴重的情況下，可能導致住院甚至死亡。
展望未來，隨著人們對該疾病的認知不斷提高以及新的、更有效的疫苗和治療方法的開發，豬流感市場預計將會成長。
此外，政府為控制豬流感蔓延和預防未來疫情爆發所做的努力也有望推動市場成長。
預計市場也將受益於對動物蛋白產品日益成長的需求，這將推動畜牧業的成長並提高對疾病預防措施的需求。

豬流感疫苗的全球市場動態

影響全球豬流感疫苗市場的關鍵市場動態：

關鍵市場促進因素

豬流感患者數量增加：全球豬流感感染人數增加是推動市場成長的主要因素，這反過來又導致對豬流感疫苗的需求增加，從而促進市場的成長。
政府推動疫苗接種計畫：提高人們對接種豬流感疫苗重要性的認知。全球各國政府為推廣疫苗接種計畫舉措，推動了市場成長。
疫苗生產和分發的進步：隨著疫苗製造商現在能夠更有效率地生產疫苗並將其分發給更多的人，技術的不斷採用將推動市場發展。
預防性醫療保健需求不斷增加：人們對預防性醫療保健益處的認知不斷提高，導致對疫苗（包括豬流感疫苗）的需求增加。
醫療保健支出不斷增加：人們對疾病預防的日益關注加上全球醫療保健支出的不斷增加預計將推動對豬流感疫苗的需求。

主要挑戰

疫苗地理分佈有限：儘管對豬流感疫苗的需求不斷成長，但仍有一些地區無法輕易獲得這些疫苗，這限制了這些地區的市場潛力。
疫苗高成本：豬流感疫苗的成本可能會對部分人口造成障礙，特別是在低收入國家，這可能會限制對疫苗的需求並阻礙市場成長。
疫苗有效性有限：豬流感病毒變異迅速，可能降低疫苗的效力。疫苗製造商將面臨挑戰，需要跟上病毒株的持續演變。
嚴格監管：豬流感疫苗市場受到嚴格監管，這可能會給製造商在獲得核准和遵守監管要求方面帶來挑戰。
疫苗猶豫：人們由於擔心副作用和對醫療保健系統缺乏信任等各種原因而猶豫是否接種豬流感疫苗，這可能會限制對疫苗的需求並阻礙市場成長。

主要趨勢：

疫苗接種擔憂加劇：人們對通用感染疾病和豬流感大流行的認知不斷提高，推動了豬隻疫苗接種需求的增加。
關注牛健康：豬隻生產商意識到豬流感疫苗接種在牛健康和防止生產損失方面具有經濟效益。
嚴格的監管措施：監管機構可能會對獸用疫苗實施更嚴格的品管措施，而政府機構可能會發布有關豬流感疫苗接種的指南，這可能會影響市場成長。

Swine influenza, also known as swine flu, is a respiratory disease caused by the influenza virus that affects pigs. The disease can also be transmitted to humans, leading to outbreaks of human swine influenza.
The global swine influenza market includes the development, manufacturing, and distribution of vaccines and treatments for the disease.
The application of swine influenza vaccines and treatments is primarily focused on preventing and treating the disease in pigs and humans. In the case of pigs, vaccination is used to prevent the spread of the disease, which can lead to significant economic losses for farmers. In humans, swine influenza vaccines and treatments are used to prevent and treat the disease, which can cause respiratory illness and, in severe cases, lead to hospitalization or death.
In terms of future scope, the swine influenza market is expected to grow with increasing awareness about the disease and the development of new and more effective vaccines and treatments.
Additionally, government initiatives to control the spread of swine influenza and prevent future outbreaks are expected to boost the growth of the market.
The market is also expected to benefit from the increasing demand for animal protein products, which is driving the growth of the livestock industry and increasing the need for disease prevention measures.

Global Swine Influenza Vaccines Market Dynamics

The key market dynamics that are shaping the global Swine Influenza Vaccines Market include:

Key Market Drivers:

Increasing Incidence of Swine Flu Cases: The rising prevalence of swine flu infections across the globe is a major factor driving the growth of the market. This has led to an increase in demand for swine flu vaccines, thereby contributing to the market growth.
Government Initiatives towards Immunization Programs: Growing awareness among people regarding the importance of vaccination against swine influenza. Governments programs around the world are taking initiatives to promote immunization programs, resulted in a boost in the growth of the market.
Advancements in Vaccine Production and Distribution: Rising adoption of technology will drive the market as vaccine manufacturers are now able to produce vaccines more efficiently and distribute them to a larger population.
Growing Demand for Preventive Healthcare: Increasing awareness about the benefits of preventive healthcare is leading to a rise in demand for vaccines, including swine flu vaccines.
Rising Healthcare Expenditure: With the increase in healthcare spending globally, there is a growing focus on disease prevention, which is expected to drive the demand for swine flu vaccines.

Key Challenges:

Limited Availability of Vaccines in Distinct Regions: Despite the growing demand for swine flu vaccines, there are still some regions where these vaccines are not readily available. This limits the market potential in these areas.
High Cost of Vaccines: The cost of swine flu vaccines can be a barrier for some individuals, especially in low-income countries. This can limit the demand for vaccines, thereby hindering the growth of the market.
Limited Efficacy of Vaccines: Swine flu viruses can mutate quickly, which can reduce the efficacy of vaccines. This can be a challenge for vaccine manufacturers to keep up with the evolving strains of the virus.
Stringent Regulations: The swine flu vaccine market is highly regulated, which can create challenges for manufacturers in terms of obtaining approvals and meeting regulatory requirements.
Vaccine Hesitancy: Some individuals may be hesitant to receive swine flu vaccines due to various reasons, such as concerns about side effects or a lack of trust in the healthcare system. This can limit the demand for vaccines and hinder the growth of the market.

Key Trends:

Growing Vaccination Concerns: The rising awareness of zoonotic diseases and the potential swine flu pandemics is driving increased demand for pig vaccination.
Focus on Herd Well-being: Pig producers are increasingly recognizing the economic benefits of swine flu vaccination for herd health and preventing production losses.
Stringent Regulatory Measures: Regulatory bodies are implementing stricter quality control measures for animal vaccines, while government agencies may issue guidelines for swine flu vaccination in pigs, potentially influencing market growth.

Global Swine Influenza Vaccines Market Regional Analysis

Here is a more detailed regional analysis of the global Swine Influenza Vaccines Market:

North America:

The increasing demand for Swine Influenza Vaccines Market is significant in North America because of the region's demand for the product occasionally surges during flu seasons or in reaction to swine flu diseases. In general, the market is growing steadily due to factors like population expansion, immunization campaigns, and public health efforts.
Witnessing a rise in the number of swine flu influenza cases in recent years. The government in Mexico has been taking various measures to improve the healthcare infrastructure in the country and increase access to vaccines, which has been driving the growth of the market in the region.
Increasing awareness regarding the importance of vaccination is also expected to drive the market for swine influenza vaccines in North America. As people become more aware of the benefits of vaccination and the risks associated with not vaccinating, they are more likely to seek out vaccines, thereby contributing to the growth of the market.

Europe:

The European Medicines Agency (EMA) and other regulatory agencies enforce strict guidelines for the approval and production of vaccines, which impacts market entrance obstacles and strategies for product differentiation.
The main factors driving the demand for swine influenza vaccines include disease outbreaks, government programs encouraging livestock health, and growing swine producer awareness of the advantages of immunization.
Furthermore, developments in vaccination technology and growing worries about the spread of zoonotic diseases are reflected in market patterns. Product innovation, price strategies, and industry-wide strategic alliances are characteristics of competitive dynamics. Overall, a comprehensive regional study reveals pathways forward and emphasizes the intricate interactions among variables influencing the European Swine Influenza Vaccines Market.

Asia Pacific:

The Asia Pacific region is an important market for swine influenza vaccines due to the high incidence of the disease in the region. A regional analysis of the market can help identify the key market trends and drivers.
Increasing demand for vaccine are expected to drive growth due to their large populations and increasing awareness about the importance of vaccination. On the supply side, many leading global players have established their manufacturing facilities in the region, which has helped to increase the availability of vaccines.
Additionally, there may be cultural barriers to vaccine adoption in some regions, which will need to be addressed through targeted marketing and education campaigns.

Global Swine Influenza Vaccines Market: Segmentation Analysis

The Global Swine Influenza Vaccines Market is segmented on the basis of Product Type, Application, And Geography.

Swine Influenza Vaccines Market, By Product Type

Live Vaccine
Killed Vaccine

Based on Product Type, The market is segmented into Live Vaccine and Killed Vaccine. The Live vaccine is dominated throughout the forecast period. Due to Live vaccines exhibit superior efficacy in conferring cross-protection against emerging strains and variants, offering a strategic advantage in combating evolving disease threats within the swine industry. Despite concerns regarding potential reversion to virulence and strict storage and handling requirements, advancements in vaccine technology and stringent quality control measures have significantly mitigated these risks, bolstering confidence among stakeholders.

Swine Influenza Vaccines Market, By Application

Commodity Pig
Breeding Pig

Based on Application, The market is segmented into Commodity Pig and Breeding Pig. The commodity pig is dominate the market often raised for meat production purposes, represent a significant portion of the swine population in Europe. Given the large-scale nature of commodity pig production and the emphasis on maximizing efficiency and productivity, disease prevention measures, including vaccination, are crucial for maintaining herd health and minimizing economic losses associated with disease outbreaks. Swine influenza vaccines play a vital role in protecting commodity pig herds from respiratory diseases, ensuring optimal growth rates and meat quality.

Key Players

The "Global Swine Influenza Vaccines Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Chengdu TECBOND,Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Merial, Ceva, Ringpu Biology, and DHN.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Swine Influenza Vaccines Market: Recent Developments
In August 2023, Boehringer ingelheim introduced new influenza vaccine for swine. They developed and sold by Boehringer Ingelheim, Ingelvac Provenza is the first live attenuated influenza vaccine for growing pigs and provides protection against the threat of influenza virus strains H1N2 and H3N21.
In June, 2023, Husker scientist has developed a robust vaccine against a strain of swine influenza. Framed by a model of nucleic acid proteins. They developed more efficient and long-lasting vaccination strategies in vulnerable pig population.

1 INTRODUCTION OF GLOBAL SWINE INFLUENZA VACCINES MARKET

1.1 Introduction of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL SWINE INFLUENZA VACCINES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL SWINE INFLUENZA VACCINES MARKET, BY PRODUCT TYPE

5.1 Overview
5.2 Live Vaccines
5.3 Killed Vaccines

6 GLOBAL SWINE INFLUENZA VACCINES MARKET, BY APPLICATION

6.1 Overview
6.2 Commodity Pig
6.3 Breeding Pig

7 GLOBAL SWINE INFLUENZA VACCINES MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East & Africa

8 GLOBAL SWINE INFLUENZA VACCINES MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Chengdu TECBOND
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Green Cross Veterinary
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Hipra
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 MSD Animal Health (Merck)
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Zoetis
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 CAHIC
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Merial
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Ceva
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Ringpu Biology
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 DHN
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments